Invizius

Invizius is a clinical-stage biotech pioneering next-generation complement therapies for inflammatory, fibrotic and autoimmune disorders. Its proprietary technology enhances natural complement regulators to optimise patient safety and efficacy. The lead product, H-Guard, now in clinical development, addresses critical unmet needs for patients undergoing dialysis and extracorporeal circuit therapies.